A Propensity Score-Adjusted Comparison of Lenalidomide plus R-CHOP Versus R-CHOP for MYC-Rearranged DLBCL Patients

被引:0
|
作者
de Jonge, A. Vera [1 ]
van Werkhoven, Erik D. [2 ]
Dinmohamed, Avinash G. [3 ]
Nijland, Marcel [4 ,5 ]
Zwinderman, Aeilko H. [6 ]
Bossuyt, Patrick M. [7 ]
Veldhuis, Martine S. [8 ]
Rutten, Emma G. G. M. [9 ]
Mous, Rogier [10 ]
Vermaat, Joost S. P. [11 ]
Sandberg, Yorick [12 ]
de Jongh, Eva [13 ]
Bilgin, Yavuz M. [14 ]
Boersma, Rinske [15 ]
Koene, Harry R. [16 ]
Kersten, Marie Jose [17 ]
de Jong, Daphne [18 ]
Chamuleau, Martine E. D. [1 ]
机构
[1] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Amsterdam UMC, Dept Hematol, Amsterdam, Netherlands
[2] Erasmus MC, Hovon Data Ctr, Dept Hematol, Canc Inst, Rotterdam, Netherlands
[3] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands
[4] Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands
[5] Univ Groningen, Groningen, Netherlands
[6] Univ Amsterdam, Amsterdam UMC, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands
[7] Locat Univ Amsterdam, Dept Clin Epidemiol, Amsterdam UMC, Biostat, Amsterdam, Netherlands
[8] Locat Vrije Univ Amsterdam, Dept Hematol, Amsterdam UMC, Amsterdam, Netherlands
[9] Locat Vrije Univ Amsterdam, Dept Pathol, Amsterdam UMC, Amsterdam, Netherlands
[10] Univ Med Ctr Utrecht, Dept Hematol, Utrecht, Netherlands
[11] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands
[12] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands
[13] Albert Schweitzer Hosp, Dept Hematol, Dordrecht, Netherlands
[14] Admiraal de Ruijter Hosp, Dept Internal Med, Goes, Netherlands
[15] Amphia Hosp, Dept Internal Med, Breda, Netherlands
[16] St Antonius Hosp, Dept Hematol, Nieuwegein, Netherlands
[17] Acad Med Ctr, Dept Hematol, Amsterdam, Netherlands
[18] Vrije Univ Amsterdam, Amsterdam UMC, Dept Pathol, Canc Ctr Amsterdam, Amsterdam, Netherlands
关键词
D O I
10.1182/blood-2022-163204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2059 / 2060
页数:2
相关论文
共 50 条
  • [31] Lenalidomide In Combination With R-CHOP (R2-CHOP) In Patients With High Burden Follicular Lymphoma: Phase 2 Study
    Tilly, Herve
    Morschhauser, Franck
    Casasnovas, Olivier
    Molina, Thierry Jo
    Mounier, Nicolas
    Salles, Gilles Andre
    Le Gouill, Steven
    Bologna, Serge
    Tournilhac, Olivier
    Cabecadas, Jose
    Bouabdallah, Reda
    Gabarre, Jean
    Lamy, Thierry
    Haioun, Corinne
    BLOOD, 2013, 122 (21)
  • [32] Correlation of bcl-6 expression with response to R-CHOP in DLBCL
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2006, 7 (02): : 104 - 105
  • [34] A Matched Comparison of Pola-R-CHP Vs. R-CHOP for DLBCL with Extranodal Involvement
    Yang, Shenmiao
    Wei, Rong
    Liu, Yang
    Dou, Xuelin
    Wen, Lei
    Lu, Jin
    Wang, Fengrong
    Mo, Xiaodong
    Huang, Xiaojun
    BLOOD, 2024, 144 : 6478 - 6479
  • [35] Response: Outcomes with R-CHOP in DLBCL leave ample room for improvement
    Winter, Jane N.
    Weller, Edie A.
    Horning, Sandre J.
    Gascoyne, Randy D.
    BLOOD, 2007, 109 (02) : 844 - 844
  • [36] Tucidinostat/R-CHOP Combo Appears Effective, Safe in DLBCL Subtype
    不详
    ONCOLOGY-NEW YORK, 2024, 38 (07):
  • [37] R-CHOP versus R-COMP: Are They Really Equally Effective?
    Mian, M.
    Wasle, I.
    Gamerith, G.
    Mondello, P.
    Melchardt, T.
    Jaeger, T.
    Linkesch, W.
    Fiegl, M.
    CLINICAL ONCOLOGY, 2014, 26 (10) : 648 - 652
  • [38] Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis
    Visco, Carlo
    Pregnolato, Francesca
    Ferrarini, Isacco
    De Marco, Beatrice
    Bonuomo, Valentina
    Sbisa, Eugenio
    Fraenza, Costanza
    Bernardelli, Andrea
    Tanasi, Ilaria
    Quaglia, Francesca Maria
    Krampera, Mauro
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 163
  • [39] Second report of clinical significance of sFas for DLBCL treated with CHOP and new analysis of sFas for DLBCL treated with R-CHOP
    Tsurumi, Hisashi
    Hara, Takeshi
    Kitagawa, Jun-ichi
    Goto, Naoe
    Kanemura, Nobuhiro
    Kasahara, Senji
    Yamada, Toshiki
    Moriwaki, Hisataka
    BLOOD, 2007, 110 (11) : 469A - 469A
  • [40] REAL-TIME CELL-OF-ORIGIN SUBTYPE IDENTIFICATION BY GENE EXPRESSION PROFILE IN THE PHASE 3 ROBUST TRIAL OF LENALIDOMIDE plus R-CHOP VS PLACEBO plus R-CHOP IN PREVIOUSLY UNTREATED ABC-TYPE DLBCL
    Vitolo, U.
    Chiappella, A.
    Witzig, T. E.
    Spina, M.
    Gascoyne, R. D.
    Zhang, L.
    Flament, J.
    Repici, J.
    Conlin, E.
    Delissio, K.
    Nowakowski, G. S.
    HAEMATOLOGICA, 2016, 101 : 392 - 392